DE19926671A1 - Anhydrous composition forming stable, transparent skin-compatible gel for use as cosmetic or dermatological base, containing fatty alcohol or its ester and silicon dioxide - Google Patents
Anhydrous composition forming stable, transparent skin-compatible gel for use as cosmetic or dermatological base, containing fatty alcohol or its ester and silicon dioxideInfo
- Publication number
- DE19926671A1 DE19926671A1 DE1999126671 DE19926671A DE19926671A1 DE 19926671 A1 DE19926671 A1 DE 19926671A1 DE 1999126671 DE1999126671 DE 1999126671 DE 19926671 A DE19926671 A DE 19926671A DE 19926671 A1 DE19926671 A1 DE 19926671A1
- Authority
- DE
- Germany
- Prior art keywords
- anhydrous composition
- composition according
- fatty alcohol
- cosmetic
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 150000002191 fatty alcohols Chemical class 0.000 title claims abstract description 19
- 239000000377 silicon dioxide Substances 0.000 title claims abstract description 9
- 235000012239 silicon dioxide Nutrition 0.000 title claims abstract description 8
- 239000002537 cosmetic Substances 0.000 title claims description 11
- 150000002148 esters Chemical class 0.000 title description 9
- -1 fatty alcohol ester Chemical class 0.000 claims abstract description 23
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000004904 UV filter Substances 0.000 claims description 5
- 230000000475 sunscreen effect Effects 0.000 claims description 5
- 239000000516 sunscreening agent Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000012876 carrier material Substances 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- 229910052814 silicon oxide Inorganic materials 0.000 claims 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 14
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- 229910002012 Aerosil® Inorganic materials 0.000 description 6
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008406 cosmetic ingredient Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229940052296 esters of benzoic acid for local anesthesia Drugs 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- OUCGJMIVSYHBEC-UHFFFAOYSA-N 2-ethylhexyl 2-ethylhexanoate Chemical compound CCCCC(CC)COC(=O)C(CC)CCCC OUCGJMIVSYHBEC-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- QRNFTMKPBPCPJO-UHFFFAOYSA-N 2-ethylhexyl hexanoate Chemical compound CCCCCC(=O)OCC(CC)CCCC QRNFTMKPBPCPJO-UHFFFAOYSA-N 0.000 description 1
- HPUAIVNIHNEYPO-UHFFFAOYSA-N 2-ethylhexyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)CCCC HPUAIVNIHNEYPO-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical compound COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- SKVCWXRLKHBEKW-UHFFFAOYSA-N 2-methylpropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(C)C SKVCWXRLKHBEKW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- CDUPASLURGOXGD-UHFFFAOYSA-N 2-propoxybenzaldehyde Chemical compound CCCOC1=CC=CC=C1C=O CDUPASLURGOXGD-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- 150000005416 4-aminobenzoic acids Chemical class 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- IBYCEACZVUOBIV-UHFFFAOYSA-N 4-methylpentyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC(C)C IBYCEACZVUOBIV-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- 229910002014 Aerosil® 130 Inorganic materials 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 229910002017 Aerosil® 255 Inorganic materials 0.000 description 1
- 229910002018 Aerosil® 300 Inorganic materials 0.000 description 1
- 229910002019 Aerosil® 380 Inorganic materials 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AMWRITDGCCNYAT-UHFFFAOYSA-L manganese oxide Inorganic materials [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 1
- PPNAOCWZXJOHFK-UHFFFAOYSA-N manganese(2+);oxygen(2-) Chemical class [O-2].[Mn+2] PPNAOCWZXJOHFK-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078555 myristyl propionate Drugs 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- YRZGMTHQPGNLEK-UHFFFAOYSA-N tetradecyl propionate Chemical compound CCCCCCCCCCCCCCOC(=O)CC YRZGMTHQPGNLEK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/31—Anhydrous
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Gegenstand der vorliegenden Erfindung ist eine wasserfreie, transparente gelförmige Zusammensetzung, welche aus einer Ölphase besteht, wobei die Ölphase mindestens einen Fettalkohol und/oder Fettalkoholester und Siliciumdioxid enthält.The present invention relates to an anhydrous, transparent gel-like Composition consisting of an oil phase, the oil phase contains at least one fatty alcohol and / or fatty alcohol ester and silicon dioxide.
Aus Ölen oder Fettkörpern bestehende gelförmige Zusammensetzungen werden allgemein als Ölgele bezeichnet und finden insbesondere im dermatologischen Bereich als Träger pharmazeutischer oder kosmetischer Wirkstoffe Verwendung. Beispielsweise als Sonnenschutzmittel.Gel-like compositions consisting of oils or fatty bodies commonly referred to as oil gels and found particularly in dermatological Area used as a carrier for pharmaceutical or cosmetic active ingredients. For example as a sunscreen.
Ölgele sind aus dem Stand der Technik bekannt und bestehen aus einem Ölkörper bzw. einer Öl- oder Fettphase und einem viskositätserhöhenden Mittel, beispielsweise Cellulosederivate, Zuckerpolymere, Stärke.Oil gels are known from the prior art and consist of an oil body or an oil or fat phase and a viscosity-increasing agent, for example cellulose derivatives, sugar polymers, starch.
Diese Art Ölgele haben jedoch insbesondere den Nachteil, daß sie in flüssigem Zustand vorliegen und somit leicht tropfen, auf einer Oberfläche (zum Beispiel Haut) schnell verlaufen können und zusätzlich meist noch klebrige Eigenschaften aufweisen.However, this type of oil gels have the particular disadvantage that they are in liquid Condition and therefore drip slightly on a surface (e.g. skin) can run quickly and also mostly sticky properties exhibit.
Aufgabe der vorliegenden Erfindung ist daher eine insbesondere für den dermatologischen Bereich verwendbare gelförmige Zusammensetzung bereitzustellen, welche verbesserte Eigenschaften gegenüber den bekannten gelförmigen Zusammensetzungen aufweist und die Nachteile des Standes der Technik beseitigt.The object of the present invention is therefore in particular for dermatological field usable gel-like composition to provide which have improved properties over the known has gel-like compositions and the disadvantages of the prior art Technology eliminated.
Die Aufgabe wurde erfindungsgemäß durch Bereitstellen einer wasserfreien, Zusammensetzung gemäß Anspruch 1 gelöst, wonach die Zusammensetzung aus einer hydrophoben Phase besteht, enthaltend eine Kombination aus mindestens einem Fettalkohol und/oder Fettalkoholester und Siliciumdioxid.The object was achieved according to the invention by providing an anhydrous, A composition as claimed in claim 1, after which the composition consists of consists of a hydrophobic phase containing a combination of at least a fatty alcohol and / or fatty alcohol ester and silicon dioxide.
Überaschenderweise wurde gefunden, daß die Verwendung einer Kombination aus mindestens einem Fettalkohol und/oder Fettalkoholester und Siliciumdioxid in einer wasserfreien, hydrophoben Phase ein transparentes, stabiles Gel ausbildet, welches ganz ausgezeichnete Eigenschaften hinsichtlich Hautverträglichkeit, Handhabbarkeit, Verwendbarkeit und Aussehen aufweist.Surprisingly, it was found that the use of a combination of at least one fatty alcohol and / or fatty alcohol ester and silicon dioxide in one anhydrous, hydrophobic phase forms a transparent, stable gel which very excellent properties with regard to skin tolerance, handling, Usability and appearance.
Es wurde festgestellt, daß die erfindungsgemäße Zusammensetzung ein verbessertes Hautgefühl, hervorragende Hautpflegeeigenschaften und hohe Hautverträglichkeit entfaltet. Außerdem zeichnet sich die erfindungsgemäße Zusammensetzung durch eine hohe Wasserfestigkeit aus. Darüber hinaus wird auch eine vorteilhafte Handhabbarkeit und multiple Verwendbarkeit erreicht, beispielsweise als nichttropfender oder nichtverfließender Träger pharmazeutischer oder kosmetischer Wirkstoffe. Durch die Transparenz erlangt die erfindungsgemäße Zusammensetzung außerdem ein vorteilhaftes Aussehen.It was found that the composition of the invention improved skin feel, excellent skin care properties and high Skin tolerance unfolds. In addition, the invention is distinguished Composition by a high water resistance. Beyond that too achieves advantageous manageability and multiple usability, for example as a non-dripping or non-flowing pharmaceutical carrier or cosmetic ingredients. The transparency according to the invention achieves Composition also has an advantageous appearance.
Insofern kann die erfindungsgemäße Zusammensetzung in hervorragender Weise verwendet werden als Trägermaterial für öllösliche kosmetische und/oder pharmazeutische Wirkstoffe, beispielsweise als Trägermaterial für öllösliche Sonnenschutzmittel oder in der Dermatologie üblicher Wundheilmittel.In this respect, the composition of the invention can be excellent are used as a carrier material for oil-soluble cosmetic and / or active pharmaceutical ingredients, for example as a carrier material for oil-soluble Sunscreens or wound healing agents common in dermatology.
Als hydrophobe Phase wird im Rahmen der Erfindung eine Öl-, Lipid-, oder Fettphase verstanden, die üblicherweise in der pharmazeutischen und kosmetischen Industrie zur Herstellung von Zusammensetzungen mit hydrophoben Phasen verwendet werden können. Insbesondere zählen hierzu pflanzliche, tierische, mineralische, synthetische oder semisynthetische Öle, welche hydrogeniert vorliegen können, oder Wachse und Gemische hiervon, Ester von gesättigten und/oder ungesättigten, verzweigten und/oder linearen Alkancarbonsäuren mit 6 bis 22 Kohlenstoffatomen oder aromatischen Carbonsäuren (beispielsweise Benzoesäure) mit gesättigten und/oder ungesättigten, verzweigten und/oder linearen Fettalkoholen mit 6 bis 22 Kohlenstoffatomen oder Alkoholen mit 6 bis 26 Kohlenstoffatomen, Paraffine, Lanolin, welches auch hydrogeniert oder acetyliert sein kann, Silikonöle. Desweiteren kommen in Betracht Guerbetalkohole auf Basis von Fettalkoholen mit 6 bis 18 Kohlenstoffatomen, Ester von linearen und/oder verzweigten Fettsäuren mit mehrwertigen Alkoholen (beispielsweise Propylenglycol) und/oder Guerbetalkoholen, Triglyceride oder flüssige Mono-/Di-/Triglyceridmischungen auf Basis von Fettsäuren mit 6 bis 20 Kohlenstoffatomen. In the context of the invention, an oil, lipid or Fat phase understood, which is usually in the pharmaceutical and cosmetic Industry for the production of compositions with hydrophobic phases can be used. In particular, this includes plant, animal, mineral, synthetic or semi-synthetic oils which are hydrogenated can, or waxes and mixtures thereof, esters of saturated and / or unsaturated, branched and / or linear alkane carboxylic acids with 6 to 22 Carbon atoms or aromatic carboxylic acids (for example benzoic acid) with saturated and / or unsaturated, branched and / or linear fatty alcohols with 6 to 22 carbon atoms or alcohols with 6 to 26 carbon atoms, Paraffins, lanolin, which can also be hydrogenated or acetylated, silicone oils. Guerbet alcohols based on fatty alcohols with 6 up to 18 carbon atoms, esters of linear and / or branched fatty acids polyhydric alcohols (e.g. propylene glycol) and / or Guerbet alcohols, Triglycerides or liquid mono- / di- / triglyceride mixtures based on fatty acids with 6 to 20 carbon atoms.
Die hydrophobe Phase der erfindungsgemäßen Zusammensetzung, welche Fettalkohol und/oder Fettalkoholester enthält, aber auch weitere öllösliche Wirkstoffe und bei Raumtemperatur flüchtige niedere Alkohole enthalten kann, liegt in einer Menge zwischen 90,0 und 99,5 Gew.-% vor, wobei eine Menge zwischen 93,0 und 97,0 Gew.-% bevorzugt ist. Die Mengenangaben sind bezogen auf die Gesamtzusammensetzung.The hydrophobic phase of the composition according to the invention, which Contains fatty alcohol and / or fatty alcohol esters, but also other oil-soluble active ingredients and may contain volatile lower alcohols at room temperature is one Amount between 90.0 and 99.5 wt .-%, with an amount between 93.0 and 97.0% by weight is preferred. The quantities are based on the Overall composition.
Die hydrophobe Phase kann aber auch allein aus Fettalkoholen und/oder Fettalkoholestern bestehen, also bis 99,5 Gew.-% aus Fettalkoholen und/oder Fettalkoholestern.However, the hydrophobic phase can also consist solely of fatty alcohols and / or Fatty alcohol esters consist of up to 99.5% by weight of fatty alcohols and / or Fatty alcohol esters.
Insofern können die Fettalkohole und/oder Fettalkoholester zwischen 0,1 Gew.-% und 99,5 Gew.-%, bezogen auf die Gesamtmenge der Zusammensetzung, in der hydrophoben Phase enthalten sein, wobei ein Mengenbereich zwischen 10,0 Gew.-% und 99,0 Gew.-%, insbesondere zwischen 30,0 Gew.-% und 95,0 Gew.-% bevorzugt ist.In this respect, the fatty alcohols and / or fatty alcohol esters can be between 0.1% by weight and 99.5% by weight, based on the total amount of the composition in which hydrophobic phase can be included, a quantity range between 10.0 wt .-% and 99.0% by weight, in particular between 30.0% by weight and 95.0% by weight, are preferred is.
Als Fettalkohole, die erfindungsgemäß verwendet werden können, kommen alle dem Fachmann bekannten Fettalkohole mit 8 bis 22 Kohlenstoffatomen in Frage, die für pharmazeutische und/oder kosmetische Präparationen üblicherweise Verwendung finden.As fatty alcohols, which can be used according to the invention, all come Fatty alcohols with 8 to 22 carbon atoms known to those skilled in the art are suitable for pharmaceutical and / or cosmetic preparations usually used Find.
Typische Beispiele für erfindungsgemäß verwendbare Fettalkohole sind:
Caprylalkohol, Caprinalkohol, Laurylalkohol, Myristylalkohol, Cetylalkohol,
Palmoleylalkohol, Oleylalkohol, Stearylalkohol, Isostearylalkohol, Kokosfettalkohol,
Cetearylalkohol, Talgfettalkohol.Typical examples of fatty alcohols which can be used according to the invention are:
Caprylic alcohol, capric alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, oleyl alcohol, stearyl alcohol, isostearyl alcohol, coconut oil alcohol, cetearyl alcohol, tallow fatty alcohol.
Als Beispiele seien genannt: Eutanol® G (INCI Bezeichnung: Octyldodecanol), aber auch Zusätze von festen Alkoholen wie beispielsweise Lanette® O (INCI Bezeichnung: Cetearyl Alcohol).Examples include: Eutanol® G (INCI name: Octyldodecanol), but also additions of solid alcohols such as Lanette® O (INCI Name: Cetearyl Alcohol).
Fettalkoholester im Sinne der vorliegenden Erfindung umfassen alle bekannten Esteröle, die in pharmazeutischen und/oder kosmetischen Präparationen üblicherweise verwendet werden. Hierzu zählen beispielsweise Methylmyristat, Ethylmyristat, Isopropylmyristat, Myristylpropionat, Ethylpalmitat, Methylpalmitat, Isopropylpalmitat, Isopropylstearat, Octylstearat, Isopropyloleat, Diisopropyladipat, 2- Ethylhexylhexanoat, 2-Ethylhexyloctanoat, 2-Ethylhexylpalmitat, 2-Ethylhexyllaurat, 2-Hexyldecylstearat, 2-Octyldodecylpalmitat, 2-Ethylhexyl-2-ethylhexanoat, Ethyllaurat, Hexyllaurat, Isohexyllaurat, Isodecylneopentanoat, Isobutylmyristat, Butylmyristat, n-Decyioleat, n-Butylstearat, Isononylisononanoat, Isononylstearat, Ester aus Benzoesäure und Alkoholen mit 6 bis 26 Kohlenstoffatomen, Ester von Fettsäuren mit Pentaerythrol, Mischester von Glycerin mit Fettsäuren, wobei auch Gemische dieser Fettalkoholester verwendet werden können.Fatty alcohol esters for the purposes of the present invention include all known Ester oils used in pharmaceutical and / or cosmetic preparations are usually used. These include, for example, methyl myristate, Ethyl myristate, isopropyl myristate, myristyl propionate, ethyl palmitate, methyl palmitate, Isopropyl palmitate, isopropyl stearate, octyl stearate, isopropyl oleate, diisopropyl adipate, 2- Ethylhexylhexanoate, 2-ethylhexyl octanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, 2-ethylhexyl-2-ethylhexanoate, Ethyl laurate, hexyl laurate, isohexyl laurate, isodecyl neopentanoate, isobutyl myristate, Butyl myristate, n-decyioleate, n-butyl stearate, isononyl isononanoate, isononyl stearate, Esters of benzoic acid and alcohols with 6 to 26 carbon atoms, esters of Fatty acids with pentaerythrol, mixed esters of glycerin with fatty acids, also Mixtures of these fatty alcohol esters can be used.
Als Fettalkoholester kommen beispielsweise in Betracht: Cetiol® 868 (INCI Bezeichnung: Octyl Stearate), Cetiol® SN (INCI Bezeichnung: Cetearyl Isononanoate), Crodamol® PTIS (INCI Bezeichnung: Pentaerythrityl Tetraisostearate), Finsolv® TN (INCI Bezeichnung: C12-15 Alkyl Benzoate) oder Myritol® 318 (INCI Bezeichnung: Caprylic/Capric Triglyceride), einzeln oder als Gemisch.Examples of suitable fatty alcohol esters are: Cetiol® 868 (INCI Name: Octyl Stearate), Cetiol® SN (INCI name: Cetearyl Isononanoate), Crodamol® PTIS (INCI name: Pentaerythrityl Tetraisostearate), Finsolv® TN (INCI name: C12-15 alkyl benzoate) or Myritol® 318 (INCI name: Caprylic / Capric Triglyceride), individually or as Mixture.
Bevorzugt werden erfindungsgemäß solche Fettalkohole und/oder Fettalkoholester, die bei Raumtemperatur, also zwischen 20°C und 25°C, in flüssigem Zustand vorliegen. Die erfindungsgemäße Verwendung solcher Fettalkohole und/oder Fettalkoholester läßt nicht nur ganz besonders vorteilhafte Zusammensetzungen hinsichtlich ihrer Konsistenz entstehen, sondern hat auch den weiteren Vorteil, daß die daraus herstellbaren Ölgele ohne zusätzliche Wärmezufuhr gebildet werden können.According to the invention, preference is given to those fatty alcohols and / or fatty alcohol esters those at room temperature, i.e. between 20 ° C and 25 ° C, in the liquid state available. The use according to the invention of such fatty alcohols and / or Fatty alcohol esters not only leave particularly advantageous compositions arise with regard to their consistency, but also has the further advantage that the resulting oil gels can be formed without additional heat can.
Das Siliciumdioxid (SiO2) oder Modifikationen hiervon können vorzugsweise in einer Menge von 1,0 bis 10,0 Gew.-%, bezogen auf die Gesamtmenge der Zusammensetzung, enthalten sein, insbesondere in einer Menge zwischen 3,0 bis 7,0 Gew.-%.The silicon dioxide (SiO 2 ) or modifications thereof can preferably be contained in an amount of 1.0 to 10.0% by weight, based on the total amount of the composition, in particular in an amount between 3.0 to 7.0% .-%.
Geeignete Produkte sind vorzugsweise solche aus der Aerosil®- oder CAB-O-SIL® Reihe, beispielsweise Aerosil® 130, Aerosil® 200, Aerosil® 255, Aerosil® 300, Aerosil® 380, Aerosil®R 202, Aerosil®US 202, Aerosil®R 812, Aerosil®R 972, Aerosil®R 974, CAB-O-SIL® Fumed Silica, CAB-O-SIL® HS-5, CAB-O-SIL® EH-5, CAB-O-SIL® LM-130, CAB-O-SlL® MS-55 oder CAB-O-SIL® M-5.Suitable products are preferably those from Aerosil® or CAB-O-SIL® Series, e.g. Aerosil® 130, Aerosil® 200, Aerosil® 255, Aerosil® 300, Aerosil® 380, Aerosil®R 202, Aerosil®US 202, Aerosil®R 812, Aerosil®R 972, Aerosil®R 974, CAB-O-SIL® Fumed Silica, CAB-O-SIL® HS-5, CAB-O-SIL® EH-5, CAB-O-SIL® LM-130, CAB-O-SlL® MS-55 or CAB-O-SIL® M-5.
Überraschenderweise wurde auch gefunden, daß die erfindungsgemäße Zusammensetzung einen vergleichsweise hohen Lichtschutzfaktor (LSF) aufweist und insbesondere einen sehr guten Schutz gegen UV-B Strahlen bewirkt. Surprisingly, it was also found that the invention Composition has a comparatively high sun protection factor (SPF) and in particular provides very good protection against UV-B rays.
Bevorzugt wird demzufolge eine wasserfreie Zusammensetzung gemäß der vorliegenden Erfindung, welche als Sonnenschutzmittel vorliegt. In diesem Fall kann der Zusammensetzung als weitere Komponente vorteilhafterweise mindestens eine öllösliche UV-Filtersubstanz hinzugefügt werden.Accordingly, an anhydrous composition according to the Present invention, which is present as a sunscreen. In this case the composition as a further component advantageously at least one Oil-soluble UV filter substance can be added.
Als öllösliche UV-Filtersubstanzen können alle bekannten öllöslichen UVA-, UVB- oder UVA/UVB-Filter, einzeln oder in Kombination miteinander, verwendet werden, die üblicherweise in bekannten kosmetischen und/oder dermatologischen Zubereitungen enthalten sind.All known oil-soluble UVA-, UVB- can be used as oil-soluble UV filter substances. or UVA / UVB filters, individually or in combination with one another, which are usually in known cosmetic and / or dermatological Preparations are included.
Für UVA-Filter kommen zum Beispiel die Derivate des Dibenzoylmethans (beispielsweise Parsol 1789 von Givaudan/Roure, INCI-Bezeichung: Butyl Methoxydibenzoylmethane) in Betracht.The derivatives of dibenzoylmethane are used for UVA filters, for example (e.g. Parsol 1789 from Givaudan / Roure, INCI name: Butyl Methoxydibenzoylmethane) into consideration.
Als Beispiele für UVB-Filter können die folgenden Verbindungen genannt werden: Benzylidencampher oder Derivate davon, insbesondere Methylbenzylidencampher (beispielsweise 3-Benzylidencampher, 3-(4-Methylenbenzyliden)-dl-campher), Derivate und Ester der Zimtsäure, insbesondere Derivate und Ester der Methoxyzimtsäure (beispielsweise 4-Methoxyzimtsäureoctylester oder 4- Methoxyzimtsäureisopentylester), Derivate und Ester der Benzoesäure, insbesondere der 4-Aminobenzoesäuren, Polyhydroxybenzoesäuren (beispielsweise Polyhydroxybenzoesäuremethylester oder Polyhydroxybenzoesäurepropylester), Ester der Salicylsäure (beispielsweise Salicylsäure(2-ethylhexyl)ester oder Salicylsäure(4-isopropylbenzyl)ester), Acrylsäureester (beispielsweise Octocrylene). Als Beispiele können genannt werden: Neo Heliopan® BB (INCI-Bezeichung: Benzophenone-3), Neo Heliopan® AV (INCI-Bezeichnung: Octyl Methoxycinnamate), Neo Heliopan® MBC (INCI-Bezeichung: 4-Methylbenzylidene Camphor), Neo Heliopan® Type 303 (INCI-Bezeichnung: Octocrylene).The following compounds can be mentioned as examples of UVB filters: Benzylidene camphor or derivatives thereof, especially methylbenzylidene camphor (for example 3-benzylidene camphor, 3- (4-methylenebenzylidene) dl-camphor), Derivatives and esters of cinnamic acid, especially derivatives and esters of Methoxycinnamic acid (e.g. octyl 4-methoxycinnamate or 4- Isopentyl methoxy cinnamate), derivatives and esters of benzoic acid, especially 4-aminobenzoic acids, polyhydroxybenzoic acids (for example Polyhydroxybenzoic acid methyl ester or polyhydroxybenzoic acid propyl ester), Esters of salicylic acid (e.g. salicylic acid (2-ethylhexyl) ester or Salicylic acid (4-isopropylbenzyl) ester), acrylic acid ester (e.g. octocrylene). Examples include: Neo Heliopan® BB (INCI name: Benzophenone-3), Neo Heliopan® AV (INCI name: Octyl Methoxycinnamate), Neo Heliopan® MBC (INCI name: 4-Methylbenzylidene Camphor), Neo Heliopan® Type 303 (INCI name: Octocrylene).
Die öllöslichen UVA-, UVB- und/oder UVB/UVA-Filter können in der erfindungsgemäßen Zusammensetzung in einer Gesamtmenge zwischen 0,1 bis 30,0 Gew.-%, insbesondere zwischen 0,5 bis 20,0 Gew.-%, vorzugsweise zwischen 1,0 und 15,0 Gew.-%, bezogen auf die Gesamtmenge der Zusammensetzung, enthalten sein. The oil-soluble UVA, UVB and / or UVB / UVA filters can be used in the composition according to the invention in a total amount between 0.1 to 30.0% by weight, in particular between 0.5 to 20.0% by weight, preferably between 1.0 and 15.0% by weight based on the total amount of the composition his.
Neben dem Siliciumdioxid als UV-Licht absorbierendes Pigment können auch andere UV-Licht absorbierende anorganische Pigmente in der erfindungsgemäßen Zusammensetzung enthalten sein. Insbesondere kommen hierfür in Wasser schwerlösliche oder unlösliche Metallverbindungen oder Halbmetallverbindungen in ionischer als auch nicht-ionischer oder in oxidierter Form in Betracht. Als Beispiele hierfür seien genannt Titanoxide (beispielsweise TiO2), Zinkoxide (beispielsweise ZnO), Aluminiumoxide (beispielsweise Al2O3), Eisenoxide (beispielsweise Fe2O3), Manganoxide (beispielsweise MnO), oder Gemische davon.In addition to the silicon dioxide as the UV light absorbing pigment, other UV light absorbing inorganic pigments can also be present in the composition according to the invention. Metal compounds or semimetal compounds which are sparingly soluble or insoluble in water, in ionic as well as non-ionic or in oxidized form, are particularly suitable for this purpose. Examples include titanium oxides (for example TiO 2 ), zinc oxides (for example ZnO), aluminum oxides (for example Al 2 O 3 ), iron oxides (for example Fe 2 O 3 ), manganese oxides (for example MnO), or mixtures thereof.
Auch kommen Pigmente in Betracht, die primär keine UV-Licht absorbierende Funktion ausüben, sondern optische Effekte ausüben, beispielsweise Glimmerpigmente.Pigments are also suitable which primarily do not absorb UV light Exercise function, but exert optical effects, for example Mica pigments.
Diese zusätzlichen anorganischen Pigmente können in der erfindungsgemäßen Zusammensetzung in einer Gesamtmenge zwischen 0,01 bis 5,0 Gew.-% enthalten sein.These additional inorganic pigments can be used in the invention Contain composition in a total amount between 0.01 to 5.0 wt .-% his.
Die weiteren öllöslichen Wirkstoffe, die für die erfindungsgemäße Zusammensetzung verwendet werden können, sind beispielsweise Vitamin A-Palmitat, Tocopherol oder Tocopherylacetat (Vitamin E und dessen Derivate), Bisabolol, Karottenöl, Nussöle, Carotin.The other oil-soluble active ingredients for the composition according to the invention Vitamin A palmitate, tocopherol or Tocopheryl acetate (vitamin E and its derivatives), bisabolol, carrot oil, nut oils, Carotene.
Betreffend bei Raumtemperatur flüchtige niedere Alkohole kommen einwertige primäre, sekundäre oder tertiäre aliphatische Alkohole mit 1 bis 4 Kohlenstoffatomen in Betracht, beispielsweise Ethanol, Propanol oder Isopropanol.Lower alcohols which are volatile at room temperature come with monohydric alcohols primary, secondary or tertiary aliphatic alcohols with 1 to 4 carbon atoms into consideration, for example ethanol, propanol or isopropanol.
Es hat sich herausgestellt, daß sich mit Zusatz von Ethanol eine ganz besonders vorteilhafte Zusammensetzung gemäß der vorliegenden Erfindung herstellen läßt, welche sich durch ein besonders transparentes Ölgel auszeichnet. Ethanol ist daher bevorzugt.It has been found that adding ethanol is very special can produce advantageous composition according to the present invention, which is characterized by a particularly transparent oil gel. Ethanol is therefore prefers.
Vorteilhafterweise kann die erfindungsgemäße Zusammensetzung zusätzlich mindestens ein synthetisches Polymer enthalten. Die synthetischen Polymere sind vorzugsweise solche aus der Gruppe der Siloxane und Silicone (beispielsweise Abil Wax® 9801D, INCI-Bezeichnung: Cetyl Dimethicone) oder der PVP-Polymere und Copolymere (beispielsweise Antaron® V 216, INCI-Bezeichnung: PVP/Hexadecene Copolymer). Bevorzugt sind jedoch Polymere aus der Gruppe der Siloxane und Silicone.The composition according to the invention can advantageously additionally contain at least one synthetic polymer. The synthetic polymers are preferably those from the group of siloxanes and silicones (for example Abil Wax® 9801D, INCI name: Cetyl Dimethicone) or the PVP polymers and Copolymers (for example Antaron® V 216, INCI name: PVP / Hexadecene Copolymer). However, polymers from the group of the siloxanes and Silicones.
Der Zusatz solcher Polymere kann die Wasserfestigkeit der erfindungsgemäßen Zusammensetzung weiter verbessern, was letztlich auch vorteilhaft Einfluß auf die Beständigkeit und die Erhöhung des LSF nehmen kann.The addition of such polymers can increase the water resistance of the invention Improve composition further, which ultimately also has an advantageous influence on the Stability and the increase in SPF can take.
Die betreffenden synthetischen Polymere können in einer Gesamtmenge zwischen 1,0 und 35 Gew.-%, insbesondere zwischen 5,0 und 30,0 Gew.-%, bezogen auf die Gesamtmenge der Zusammensetzung, enthalten sein.The synthetic polymers in question can be in a total amount between 1.0 and 35 wt .-%, in particular between 5.0 and 30.0 wt .-%, based on the Total amount of the composition.
Ferner hat es sich als vorteilhaft herausgestellt, wenn die erfindungsgemäße Zusammensetzung keinen Emulgator enthält. Hierdurch wird erreicht, daß die Zusammensetzung sehr hautverträglich wird, hervorragende Hautpflege- Eigenschaften entfaltet und ein angenehmes Gefühl vermittelt.Furthermore, it has proven to be advantageous if the invention Composition contains no emulsifier. This ensures that the Composition becomes very skin-friendly, excellent skin care Properties unfolded and conveyed a pleasant feeling.
Bekannt ist, daß Emulgatoren allergische Reaktionen auslösen und unter UV-Licht Dermatosen verursachen oder die unerwünschte Penetration von chemischen Substanzen in die Haut fördern können.It is known that emulsifiers trigger allergic reactions and under UV light Cause dermatosis or the unwanted penetration of chemical Can promote substances into the skin.
Eine emulgatorfreie Zusammensetzung im Rahmen der vorliegenden Erfindung ist daher ein bevorzugter Gegenstand.An emulsifier-free composition is within the scope of the present invention hence a preferred item.
Die erfindungsgemäße Zusammensetzung weist eine gelförmige Struktur auf, so daß damit eine besonders vorteilhafte Handhabung erreicht wird. So wird beispielsweise ein Verlaufen auf der Haut oder ein Abtropfen bei der Verwendung verhindert. Selbstverständlich kann die erfindungsgemäße Zusammensetzung alle für Haut- und Haarkosmetika üblichen und bekannten Zusatz-, Hilfs- und Trägerstoffe enthalten.The composition according to the invention has a gel-like structure, so that so that a particularly advantageous handling is achieved. For example prevents bleeding on the skin or dripping during use. Of course, the composition of the invention can all for skin and Hair cosmetics contain customary and known additives, auxiliaries and carriers.
Grundsätzlich ist dem Fachmann bekannt, welche Zusatz-, Hilfs- und Trägerstoffe in der Haar- und Hautkosmetik verwendet werden, so daß die näheren Ausführungen nur beispielhaften Charakter haben und nur zur weiteren Veranschaulichung der vorliegenden Erfindung dienen sollen.In principle, the person skilled in the art knows which additives, auxiliaries and carriers in the hair and skin cosmetics are used, so that the detailed explanations only have exemplary character and only for further illustration of the are intended to serve the present invention.
Im übrigen kann hierzu auf die vorliegende Literatur verwiesen werden, die den allgemeinen Aufbau von kosmetischen Zusammensetzungen beschreiben, beispielsweise SCHRADER, K., Grundlagen und Rezepturen der Kosmetika, 2. Auflage, 1989, oder DOMSCH, A., Die kosmetischen Präparate, Verlag für chemische Industrie (H. Ziolkowsky, Ed.), 4. Auflage, 1992, oder LOWE, N. J. & SHAAT, N. A., Suncreens, Development, Evaluation and Regulatory Aspects, Marcel Dekker Inc., 1990.For the rest, reference can be made to the present literature, which the describe the general structure of cosmetic compositions, for example SCHRADER, K., basics and formulations of cosmetics, 2. Edition, 1989, or DOMSCH, A., The cosmetic preparations, publishing house for chemical Industry (H. Ziolkowsky, Ed.), 4th edition, 1992, or LOWE, N.J. & SHAAT, N.A., Suncreens, Development, Evaluation and Regulatory Aspects, Marcel Dekker Inc., 1990.
Als Zusatz-, Hilfs- und Trägerstoffe seien daher beispielhaft nur einige genannt, wobei diese Aufzählung nicht abschließend ist: Pflegestoffe (wie zum Beispiel Lanolinderivate, Vitamine oder Provitamine), Antifettwirkstoffe, Konservierungsmittel (wie zum Beispiel Parahydroxybenzoesäure-Ester), nichtwässrige Lösungsmittel, Antioxidantien (wie zum Beispiel Tocopherole oder Ester davon), Farbstoffe sowie Duftstoffe bzw. Parfüme.Only a few may therefore be mentioned as examples of additives, auxiliaries and carriers, wherein this list is not exhaustive: care substances (such as Lanolin derivatives, vitamins or provitamins), anti-fatty substances, preservatives (such as parahydroxybenzoic acid esters), non-aqueous solvents, Antioxidants (such as tocopherols or esters thereof), dyes as well Fragrances or perfumes.
Die Zusatz-, Hilfs- und Trägerstoffe können in den für den Fachmann bekannten üblichen Mengen verwendet und nach an sich bekannten Methoden eingearbeitet werden.The additives, auxiliaries and carriers can be those known to those skilled in the art usual amounts used and incorporated by methods known per se become.
Die folgenden Beispiele sollen die vorliegende Erfindung näher erläutern, wobei die angegebenen Prozente Gewichtsprozente darstellen und auf die Gesamtmenge bzw. das Gesamtgewicht der Zusammensetzungen bezogen sind.The following examples are intended to explain the present invention in more detail, the percentages are percentages by weight and refer to the total amount or the total weight of the compositions are based.
Die in den Beispielen angegebenen Einzelsubstanzen und Rohstoffe sind kommerziell erhältlich. Auch kann auf bekannte Literatur verwiesen werden, beispielsweise auf International Cosmetic Ingredient Dictionary and Handbook, Seventh Edition, 1997. The individual substances and raw materials specified in the examples are commercial available. Reference can also be made to known literature, for example to International Cosmetic Ingredient Dictionary and Handbook, Seventh Edition, 1997.
Das fertige Gel mit Silica aus Beispiel 7 wurde mit 6,0% Ethanol versetzt, es blieb
dabei klar und gelförmig
The finished gel with silica from Example 7 was mixed with 6.0% ethanol, it remained clear and gel-like
Claims (12)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999126671 DE19926671A1 (en) | 1999-06-11 | 1999-06-11 | Anhydrous composition forming stable, transparent skin-compatible gel for use as cosmetic or dermatological base, containing fatty alcohol or its ester and silicon dioxide |
| GB0014223A GB0014223D0 (en) | 1999-06-11 | 2000-06-09 | Anhydrous gel-form composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999126671 DE19926671A1 (en) | 1999-06-11 | 1999-06-11 | Anhydrous composition forming stable, transparent skin-compatible gel for use as cosmetic or dermatological base, containing fatty alcohol or its ester and silicon dioxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE19926671A1 true DE19926671A1 (en) | 2000-12-14 |
Family
ID=7910934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1999126671 Withdrawn DE19926671A1 (en) | 1999-06-11 | 1999-06-11 | Anhydrous composition forming stable, transparent skin-compatible gel for use as cosmetic or dermatological base, containing fatty alcohol or its ester and silicon dioxide |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE19926671A1 (en) |
| GB (1) | GB0014223D0 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2418141A (en) * | 2004-09-01 | 2006-03-22 | Ciba Sc Holding Ag | Micro-particulate organic UV absorber composition |
| WO2006097235A1 (en) * | 2005-03-17 | 2006-09-21 | Cognis Ip Management Gmbh | Cosmetic compositions containing esters based on 2-propylheptanol |
| WO2007140442A3 (en) * | 2006-05-31 | 2008-01-31 | Neutrogena Corp | Clear sunscreen compositions |
| WO2012149355A1 (en) | 2011-04-27 | 2012-11-01 | Isp Investments Inc. | Clear wet sprays and gels |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3239181A1 (en) * | 1981-10-23 | 1983-05-05 | L'Oreal, 75008 Paris | WATER-FREE, OXYDATION-STABLE AGENT FOR TREATING THE SKIN |
| DE3530914A1 (en) * | 1984-08-30 | 1986-03-13 | Oreal | WATER-FREE, OXIDATION-STABLE, ANTHRALINE-CONTAINING AGENT |
| US4894222A (en) * | 1988-04-04 | 1990-01-16 | Neutrogena Corporation | Waterproof sunscreen |
| WO1995011000A1 (en) * | 1993-10-18 | 1995-04-27 | The Procter & Gamble Company | Non-sweating lipsticks |
| US5849276A (en) * | 1996-12-20 | 1998-12-15 | Procter & Gamble | Antiperspirant gel-solid stick compositions containing select nucleating agents |
-
1999
- 1999-06-11 DE DE1999126671 patent/DE19926671A1/en not_active Withdrawn
-
2000
- 2000-06-09 GB GB0014223A patent/GB0014223D0/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3239181A1 (en) * | 1981-10-23 | 1983-05-05 | L'Oreal, 75008 Paris | WATER-FREE, OXYDATION-STABLE AGENT FOR TREATING THE SKIN |
| DE3530914A1 (en) * | 1984-08-30 | 1986-03-13 | Oreal | WATER-FREE, OXIDATION-STABLE, ANTHRALINE-CONTAINING AGENT |
| US4894222A (en) * | 1988-04-04 | 1990-01-16 | Neutrogena Corporation | Waterproof sunscreen |
| WO1995011000A1 (en) * | 1993-10-18 | 1995-04-27 | The Procter & Gamble Company | Non-sweating lipsticks |
| US5849276A (en) * | 1996-12-20 | 1998-12-15 | Procter & Gamble | Antiperspirant gel-solid stick compositions containing select nucleating agents |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2418141A (en) * | 2004-09-01 | 2006-03-22 | Ciba Sc Holding Ag | Micro-particulate organic UV absorber composition |
| WO2006097235A1 (en) * | 2005-03-17 | 2006-09-21 | Cognis Ip Management Gmbh | Cosmetic compositions containing esters based on 2-propylheptanol |
| CN101141944B (en) * | 2005-03-17 | 2012-05-23 | 考格尼斯知识产权管理有限责任公司 | Cosmetic compositions containing esters based on 2-propylheptanol |
| KR101330963B1 (en) * | 2005-03-17 | 2013-11-18 | 코그니스 아이피 매니지먼트 게엠베하 | Cosmetic compositions containing esters based on 2-propylheptanol |
| US8642652B2 (en) | 2005-03-17 | 2014-02-04 | Cognis Ip Management Gmbh | Cosmetic compositions containing esters based on 2-propylheptanol |
| US9314414B2 (en) | 2005-03-17 | 2016-04-19 | Cognis Ip Management Gmbh | Cosmetic compositions containing esters based on 2-propylheptanol |
| US9314413B2 (en) | 2005-03-17 | 2016-04-19 | Cognis Ip Management Gmbh | Cosmetic compositions containing esters based on 2-propylheptanol |
| WO2007140442A3 (en) * | 2006-05-31 | 2008-01-31 | Neutrogena Corp | Clear sunscreen compositions |
| WO2012149355A1 (en) | 2011-04-27 | 2012-11-01 | Isp Investments Inc. | Clear wet sprays and gels |
Also Published As
| Publication number | Publication date |
|---|---|
| GB0014223D0 (en) | 2000-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69502657T2 (en) | Cosmetic filter compositions containing an acidic hydrophilic agent and their use | |
| DE69800025T2 (en) | Cosmetic sunscreens containing a UV filter, a dispersion of non-film-forming, polymeric particles and an oil phase | |
| DE10012413A1 (en) | Use of sunscreen combinations containing as essential constituent 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations | |
| DE10012408A1 (en) | Use of sunscreen combinations which contain as essential constituent amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations | |
| EP1280505B1 (en) | Photostabilization of dibenzoylmethane derivatives | |
| DE69832020T2 (en) | Sunscreen compositions containing a Benzylidencampher- and / or a Dibenzolmethan- and / or a triazine derivative and a dialkyl tartrate, and their use in cosmetics | |
| DE69511621T2 (en) | Cosmetic sunscreens containing specific oils and uses | |
| DE19933464A1 (en) | Cosmetic or dermatological dispersions having radical scavenging and antioxidant activity, useful e.g. for preventing skin aging and inflammatory reactions | |
| DE19756377A1 (en) | Enhancing light protection factor of sun screen preparations containing UV filter compound | |
| EP1363592B1 (en) | Skin oils from oily constituants | |
| DE19651478A1 (en) | Sunscreen preparations containing surface-active mono- or oligoglyceryl compounds, water-soluble UV filter substances and optionally inorganic micropigments | |
| WO1994018942A1 (en) | Synergistic combinations of sunscreening substances, cosmetic and dermatological compositions containing such combinations | |
| DE19545789C2 (en) | Use of isoalkanoic acids | |
| DE10063946A1 (en) | Use of light stabilizer combinations which contain 2,2'-p-phenylene-bis (3,1-benzoxazin-4-one) as an essential constituent as a photostable UV filter in cosmetic and pharmaceutical preparations | |
| EP1588693B1 (en) | Improved solubiliser/solvent for organic uv-filters | |
| EP1423083A1 (en) | Stabilisation of oxidation-sensitive and uv-sensitive active ingredients | |
| DE19926671A1 (en) | Anhydrous composition forming stable, transparent skin-compatible gel for use as cosmetic or dermatological base, containing fatty alcohol or its ester and silicon dioxide | |
| EP2421502B1 (en) | Composition comprising glycyrrhetic acid for repairing previously incurred damaged to skin dna | |
| EP3411007B1 (en) | Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyldimethicone as an emulgator, largely free of silicone oils | |
| DE19739349A1 (en) | Use of troxerutin as antioxidant and/or radical scavenger | |
| DE19713776A1 (en) | Light protection preparations with a content of basic amino acids and water-soluble UV filter substances | |
| DE19651055B4 (en) | Cosmetic and dermatological sunscreen formulations containing triazine derivatives and dimethyl isosorbide and their use | |
| EP0803244B1 (en) | Use of mono- and diesters of branched alkanecarboxylic acids and diglycerine or triglycerine for the solubilsation of triazine derivatives in cosmetic and dermatological photoprotective compositions | |
| EP0895775B1 (en) | Lightprotection compositions containing inorganic pigments which are coated on their surface with UV filter substances | |
| DE19856947A1 (en) | Sunscreen comprises oil and aqueous phases, and contains inorganic pigment, alkanol or aromatic ether alcohol to improve protective effect and water resistance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8139 | Disposal/non-payment of the annual fee |